141 related articles for article (PubMed ID: 29755535)
21. Optimization of madecassoside liposomes using response surface methodology and evaluation of its stability.
Wang H; Liu M; Du S
Int J Pharm; 2014 Oct; 473(1-2):280-5. PubMed ID: 25014372
[TBL] [Abstract][Full Text] [Related]
22. Formulation and characterization of alprazolam-loaded nanoliposomes: screening of process variables and optimizing characteristics using RSM.
Hashemi SH; Montazer M; Naghdi N; Toliyat T
Drug Dev Ind Pharm; 2018 Feb; 44(2):296-305. PubMed ID: 29022858
[TBL] [Abstract][Full Text] [Related]
23. [Optimization of Formulation and Process of Paclitaxel PEGylated Liposomes by Box-Behnken Response Surface Methodology].
Shi YJ; Zhang XF; Guo QT
Zhong Yao Cai; 2015 Dec; 38(12):2606-10. PubMed ID: 27352544
[TBL] [Abstract][Full Text] [Related]
24. Modifying the release properties of liposomes toward personalized medicine.
Cipolla D; Wu H; Gonda I; Eastman S; Redelmeier T; Chan HK
J Pharm Sci; 2014 Jun; 103(6):1851-62. PubMed ID: 24715635
[TBL] [Abstract][Full Text] [Related]
25. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
Padamwar MN; Pokharkar VB
Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
[TBL] [Abstract][Full Text] [Related]
26. Membrane interactions of ternary phospholipid/cholesterol bilayers and encapsulation efficiencies of a RIP II protein.
Manojlovic V; Winkler K; Bunjes V; Neub A; Schubert R; Bugarski B; Leneweit G
Colloids Surf B Biointerfaces; 2008 Jul; 64(2):284-96. PubMed ID: 18359207
[TBL] [Abstract][Full Text] [Related]
27. Encapsulation of an endostatin peptide in liposomes: Stability, release, and cytotoxicity study.
Rezaei N; Mehrnejad F; Vaezi Z; Sedghi M; Asghari SM; Naderi-Manesh H
Colloids Surf B Biointerfaces; 2020 Jan; 185():110552. PubMed ID: 31648117
[TBL] [Abstract][Full Text] [Related]
28. Liposomal formulation for co-delivery of paclitaxel and lapatinib, preparation, characterization and optimization.
Ravar F; Saadat E; Kelishadi PD; Dorkoosh FA
J Liposome Res; 2016 Sep; 26(3):175-87. PubMed ID: 26266828
[TBL] [Abstract][Full Text] [Related]
29. A hydroxyethylated cholesterol-based cationic lipid for DNA delivery: effect of conditioning.
Percot A; Briane D; Coudert R; Reynier P; Bouchemal N; Lièvre N; Hantz E; Salzmann JL; Cao A
Int J Pharm; 2004 Jun; 278(1):143-63. PubMed ID: 15158957
[TBL] [Abstract][Full Text] [Related]
30. Characterization and stability of various liposome-encapsulated enoxacin formulations.
Fang JY; Lin HH; Hsu LR; Tsai YH
Chem Pharm Bull (Tokyo); 1997 Sep; 45(9):1504-9. PubMed ID: 9332003
[TBL] [Abstract][Full Text] [Related]
31. Tuning Ciprofloxacin Release Profiles from Liposomally Encapsulated Nanocrystalline Drug.
Cipolla D; Wu H; Eastman S; Redelmeier T; Gonda I; Chan HK
Pharm Res; 2016 Nov; 33(11):2748-62. PubMed ID: 27439506
[TBL] [Abstract][Full Text] [Related]
32. RGD-Modified Nano-Liposomes Encapsulated Eptifibatide with Proper Hemocompatibility and Cytotoxicity Effect.
Bardania H; Shojaosadati SA; Kobarfard F; Morshedi D; Aliakbari F; Tahoori MT; Roshani E
Iran J Biotechnol; 2019 Apr; 17(2):e2008. PubMed ID: 31457055
[TBL] [Abstract][Full Text] [Related]
33. Cholesterol-based anionic long-circulating cisplatin liposomes with reduced renal toxicity.
Kuang Y; Liu J; Liu Z; Zhuo R
Biomaterials; 2012 Feb; 33(5):1596-606. PubMed ID: 22079777
[TBL] [Abstract][Full Text] [Related]
34. Design, optimization and characterization of coenzyme Q10- and D-panthenyl triacetate-loaded liposomes.
Çelik B; Sağıroğlu AA; Özdemir S
Int J Nanomedicine; 2017; 12():4869-4878. PubMed ID: 28744121
[TBL] [Abstract][Full Text] [Related]
35. The Influence of Pluronic F68 and F127 Nanocarrier on Physicochemical Properties,
Shaarani S; Hamid SS; Mohd Kaus NH
Pharmacognosy Res; 2017; 9(1):12-20. PubMed ID: 28250648
[TBL] [Abstract][Full Text] [Related]
36. Effect of cysteamine hydrochloride-loaded liposomes on skin depigmenting and penetration.
Atallah C; Viennet C; Robin S; Ibazizen S; Greige-Gerges H; Charcosset C
Eur J Pharm Sci; 2022 Jan; 168():106082. PubMed ID: 34822973
[TBL] [Abstract][Full Text] [Related]
37. Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery.
Dong Y; Dong P; Huang D; Mei L; Xia Y; Wang Z; Pan X; Li G; Wu C
Eur J Pharm Biopharm; 2015 Apr; 91():82-90. PubMed ID: 25643990
[TBL] [Abstract][Full Text] [Related]
38. Quantitative Cryo-TEM Reveals New Structural Details of Doxil-Like PEGylated Liposomal Doxorubicin Formulation.
Nordström R; Zhu L; Härmark J; Levi-Kalisman Y; Koren E; Barenholz Y; Levinton G; Shamrakov D
Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33478023
[TBL] [Abstract][Full Text] [Related]
39. Flurbiprofen-loaded ethanolic liposome particles for biomedical applications.
Paliwal S; Tilak A; Sharma J; Dave V; Sharma S; Verma K; Tak K; Reddy KR; Sadhu V
J Microbiol Methods; 2019 Jun; 161():18-27. PubMed ID: 30951793
[TBL] [Abstract][Full Text] [Related]
40. Enhancing encapsulation of filarial antigen
Balasubramaniyan M; Vinayagam V; Kizhakedathil MPJ; Perumal K
ADMET DMPK; 2024; 12(2):379-389. PubMed ID: 38720924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
